10.1182/blood-2012-03-417253 - Prediagnosis biomarkers of insulin-li...

This document has been corrected

Prediagnosis biomarkers of insulin-like growth factor-1, insulin, and interleukin-6 dysregulation and multiple myeloma risk in the Multiple Myeloma Cohort Consortium

10.1182/blood-2012-03-417253

Published Online: 2012-12-13

Journal: Blood•Publisher: American Society of Hematology

Authors: Bernard Rosner•Brenda M. Birmann•Demetrius Albanes•Gianluca Severi•Graham A. Colditz•Graham G. Giles•I-Min Lee•Jarmo Virtamo•Jian-Min Yuan•JoAnn E. Manson•Julie E. Buring•Kenneth C. Anderson•Lawrence Lessin•Marian L. Neuhouser•Mark P. Purdue•Michael Pollak•Nader Rifai•Nathaniel Rothman•Ola Landgren•Patricia Hartge•Qing Lan•Robert B. Wallace

This document has been corrected

Prediagnosis biomarkers of insulin-like growth factor-1, insulin, and interleukin-6 dysregulation and multiple myeloma risk in the Multiple Myeloma Cohort Consortium

10.1182/blood-2012-03-417253

Published Online: 2012-12-13

Journal: Blood

NOW

2014-09-11•Erratum

Birmann BM, Neuhouser ML, Rosner B, et al. Prediagnosis biomarkers of insulin-like growth factor-1, insulin, and interleukin-6 dysregulation and multiple myeloma risk in the Multiple Myeloma Cohort Consortium. Blood. 2012;120(25):4929-4937.

10.1182/blood-2014-07-593012

* information provided by CrossRef

2014-09-11•Erratum

10.1182/blood-2014-07-593012

* information provided by CrossRef

2012-12-13•Published

2014-09-11•Erratum

10.1182/blood-2014-07-593012

* information provided by CrossRef

This document has been corrected

Prediagnosis biomarkers of insulin-like growth factor-1, insulin, and interleukin-6 dysregulation and multiple myeloma risk in the Multiple Myeloma Cohort Consortium

10.1182/blood-2012-03-417253

Published Online: 2012-12-13

Journal: Blood•Publisher: American Society of Hematology